Logo
x

Search

Subscribe Now

licensing agreement

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

  • October 13, 2021
Chugai and Sanofi to Terminate their Licensing Agreement for Tofogliflozin Hydrate in Japan

Chugai and Sanofi to Terminate their Licensing Agreement for Tofogliflozin Hydrate in Japan

  • February 18, 2020
Equillium Expands its Exclusive Licensing Agreement with Biocon for Itolizumab

Equillium Expands its Exclusive Licensing Agreement with Biocon for Itolizumab

  • December 13, 2019
Boehringer Ingelheim Enters into a Licensing Agreement with Lupin to Expand its KRAS Cancer Program

Boehringer Ingelheim Enters into a Licensing Agreement with Lupin to Expand its KRAS Cancer Program

  • September 4, 2019
Cantargia Extends Licensing Agreement with BioWa for its POTELLIGENT Technology

Cantargia Extends Licensing Agreement with BioWa for its POTELLIGENT Technology

  • August 23, 2019
Newsoara Biopharma Signs a Licensing Agreement with Zenith Epigenetics for its ZEN-3694

Newsoara Biopharma Signs a Licensing Agreement with Zenith Epigenetics for its ZEN-3694

  • August 7, 2019
KaliVir and Roche Enters into a Global Licensing Agreement to Discover, Develop and Commercialize Novel Oncolytic Vaccinia Viruses

    KaliVir and Roche Enters into a Global Licensing Agreement to Discover, Develop and Commercialize Novel Oncolytic Vaccinia Viruses

    • May 26, 2022
    Everest Medicines and Singapore

      Everest Medicines and Singapore's EDDC Enters into a Global Licensing Agreement to Develop and Commercialize EDDC’s 3CL Protease I...

      • January 14, 2022
      DURECT Corporation Enters a $136M Licensing Agreement with Innocoll Biotherapeutics for Posimir (Bupivacaine Solution)

        DURECT Corporation Enters a $136M Licensing Agreement with Innocoll Biotherapeutics for Posimir (Bupivacaine Solution)

        • December 23, 2021
        Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

          Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

          • October 13, 2021
          CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003

            CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003

            • October 27, 2020
            Merck Signs an Out-Licensing Agreement with Novartis for M6495 (Anti-ADAMTS5 Nanobody) for Osteoarthritis

              Merck Signs an Out-Licensing Agreement with Novartis for M6495 (Anti-ADAMTS5 Nanobody) for Osteoarthritis

              • October 7, 2020
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.